ADHD Overdiagnosis Crisis: Is Science Finally Challenging the Ritalin Regime?

The extremism around the question of how to treat gender dysphoria has begun to erode under the pressure of science and common sense. Is it possible that the same will happen regarding ADHD?

A long New York Times Magazine piece skeptical of the ADHD consensus, by Paul Tough, published about a week ago, could be an inflection point in the debate and, one hopes, lead to a fundamental reconsideration of how we think about this overdiagnosed, overprescribed, highly ambiguous disorder.

About the Author

Rich Lowry

Rich Lowry is the editor in chief of National Review.

Featured Tags

Manage following

Health

Childcare

The extremism around the question of how to treat gender dysphoria has begun to erode under the pressure of science and common sense. Is it possible that the same will happen regarding ADHD?

A long New York Times Magazine piece skeptical of the ADHD consensus, by Paul Tough, published about a week ago, could be an inflection point in the debate and, one hopes, lead to a fundamental reconsideration of how we think about this overdiagnosed, overprescribed, highly ambiguous disorder.